| The amyloid cascade hypothesis in Alzheimer’s disease: it’s time to change our mind R Ricciarelli, E Fedele Current Neuropharmacology 15 (6), 926-935, 2017 | 478 | 2017 |
| Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations M Pierantozzi, A Pietroiusti, L Brusa, S Galati, A Stefani, G Lunardi, ... Neurology 66 (12), 1824-1829, 2006 | 238 | 2006 |
| "In vivo" studies of the cerebral glutamate receptor/NO/cGMP pathway E Fedele, M Raiteri Progress in neurobiology 58 (1), 89-120, 1999 | 179 | 1999 |
| Evidence of a role for cyclic ADP‐ribose in calcium signalling and neurotransmitter release in cultured astrocytes C Verderio, S Bruzzone, E Zocchi, E Fedele, U Schenk, A De Flora, ... Journal of neurochemistry 78 (3), 646-657, 2001 | 178 | 2001 |
| GEBR‐7b, a novel PDE4D selective inhibitor that improves memory in rodents at non‐emetic doses O Bruno1, E Fedele1, J Prickaerts, LA Parker, E Canepa, C Brullo, ... British journal of pharmacology, 2011 | 152 | 2011 |
| Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients A Stefani, E Fedele, S Galati, O Pepicelli, S Frasca, M Pierantozzi, ... Annals of neurology 57 (3), 448-452, 2005 | 143 | 2005 |
| Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease S Galati, P Mazzone, E Fedele, A Pisani, A Peppe, M Pierantozzi, L Brusa, ... European Journal of Neuroscience 23 (11), 2923-2928, 2006 | 142 | 2006 |
| Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D ASR Sierksma, DLA van den Hove, F Pfau, M Philippens, O Bruno, ... Neuropharmacology 77, 120-130, 2014 | 141 | 2014 |
| Cyclo‐oxygenase‐1 and ‐2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N‐methyl‐d‐aspartate receptors … O Pepicelli, E Fedele, M Berardi, M Raiteri, G Levi, A Greco, ... Journal of neurochemistry 93 (6), 1561-1567, 2005 | 133 | 2005 |
| LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex MD Cirnaru, A Marte, E Belluzzi, I Russo, M Gabrielli, F Longo, L Arcuri, ... Frontiers in Molecular Neuroscience 7, 49, 2014 | 114 | 2014 |
| Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine A Pittaluga, E Fedele, M Raiteri Journal of Neurochemistry 61 (Suppl. S), S175, 1993 | 102 | 1993 |
| Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients M Pierantozzi, A Pietroiusti, G Sancesario, G Lunardi, E Fedele, ... Neurological Sciences 22, 89-91, 2001 | 96 | 2001 |
| Nicotine administration stimulates the in vivo N‐methyl‐D‐aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release E Fedele, G Varnier, M Antonia Ansaldo, M Raiteri British Journal of Pharmacology 125 (5), 1042-1048, 1998 | 95 | 1998 |
| In vivo activation of N‐methyl‐d‐aspartate receptors in the rat hippocampus increases prostaglandin E2 extracellular levels and triggers lipid peroxidation through … O Pepicelli, E Fedele, G Bonanno, M Raiteri, MA Ajmone‐Cat, A Greco, ... Journal of neurochemistry 81 (5), 1028-1034, 2002 | 92 | 2002 |
| Acetylcholine release from rat hippocampal slices is modulated by 5-hydroxytryptamine G Maura, E Fedele, M Raiteri European journal of pharmacology 165 (2-3), 173-179, 1989 | 85 | 1989 |
| Nearly 30 years of animal models to study amyotrophic lateral sclerosis: a historical overview and future perspectives T Bonifacino, RA Zerbo, M Balbi, C Torazza, G Frumento, E Fedele, ... International journal of molecular sciences 22 (22), 12236, 2021 | 83 | 2021 |
| Amyloid-beta peptide is needed for cGMP-induced long-term potentiation and memory A Palmeri, R Ricciarelli, W Gulisano, D Rivera, C Rebosio, E Calcagno, ... Journal of Neuroscience 37 (29), 6926-6937, 2017 | 83 | 2017 |
| Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer's disease. R Ricciarelli, C Brullo, J Prickaerts, O Arancio, C Villa, C Rebosio, ... Scientific Reports 7, 46320, 2017 | 81 | 2017 |
| Glutamate‐mediated overexpression of CD38 in astrocytes cultured with neurones S Bruzzone, C Verderio, U Schenk, E Fedele, E Zocchi, M Matteoli, ... Journal of neurochemistry 89 (1), 264-272, 2004 | 80 | 2004 |
| In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway E Fedele, Y Jin, G Varnier, M Raiteri British journal of pharmacology 119 (3), 590-594, 1996 | 78 | 1996 |
Salvatore GalatiNeurocenter of Southern SwitzerlandVerified email at eoc.ch
